Inventaire - i tuoi amici e le tue comunità sono la tua biblioteca - Inventaire

Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer

autore

Tommaso De Marchi

Paul N Span

Fred Sweep

Barbro K Linderholm

Anita Mangia

Anieta M Sieuwerts

John W Martens

John A Foekens

Maxime P Look

Arzu Umar

Marcel Smid

Theo M Luider

Christoph Stingl

pubblicato in: Journal of the National Cancer Institute

data di pubblicazione: 2014-01-07

lingua: inglese

argomento principale: tumore della mammella

Cita articoli 34

Data

Titolo

Autori

2013-09-13

Quantitative proteomic analysis of microdissected breast cancer tissues: comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches

Tommaso De Marchi
2013-01-04

The effect of folate-related SNPs on clinicopathological features, response to neoadjuvant treatment and survival in pre- and postmenopausal breast cancer patients

Nataliya Babyshkina, Maria Nazarenko, Nadezda V. Cherdyntseva
2012-09-25

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas

Liang-Chuan Lai, Mong-Hsun Tsai, Chuhsing Kate Hsiao
2012-05-30

Proteomics pipeline for biomarker discovery of laser capture microdissected breast cancer tissue
2012-01-17

A gene signature for predicting outcome in patients with basal-like breast cancer
2012-12-03

Folic acid enforces DNA methylation-mediated transcriptional silencing of PTEN, APC and RARbeta2 tumour suppressor genes in breast cancer

Katarzyna Lubecka, Agnieszka Kaufman-Szymczyk, Krystyna Fabianowska-Majewska
2012-03-13

Proteomic portrait of human breast cancer progression identifies novel prognostic markers

William M. Gallagher, Jürgen Cox, Matthias Mann
2012-07-01

Effect of genetic polymorphisms on therapeutic response and clinical outcomes in pancreatic cancer patients treated with gemcitabine.
2011-10-06

A clinically relevant gene signature in triple negative and basal-like breast cancer

Thomas Karn
2011-07-01

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Brian D. Lehmann, Jennifer A. Pietenpol
2011-11-08

Deep proteome and transcriptome mapping of a human cancer cell line

Martin Kircher, Janet Kelso, Svante Pääbo, Jürgen Cox, Matthias Mann
2011-06-03

Molecular chaperones as a common set of proteins that regulate the invasion phenotype of head and neck cancer

Ann-Joy Cheng, Chun-Ta Liao
2011-08-30

Challenges translating breast cancer gene signatures into the clinic

Jorge Reis-Filho, Britta Weigelt, Alan Ashworth
2011-08-01

Differential effect of polymorphisms of CMPK1 and RRM1 on survival in advanced non-small cell lung cancer patients treated with gemcitabine or taxane/cisplatinum

Jae Hwa Cho
2010-10-14

A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer

Laura Esserman
2010-08-01

Proteomic profiling of proteins associated with lymph node metastasis in colorectal cancer
2010-03-01

Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene.
2009-03-27

Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer

Hyuk Kang
2009-02-01

Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance

Stefan Sleijfer
2008-12

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
2008-10-02

Ferritin for the clinician

Lan Coffman, Frank M. Torti, Suzy V. Torti
2008-03-01

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

Maggie Chon U Cheang, Charles M. Perou
2007-10-22

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

Larry Norton, Robert C. Bast, American Society of Clinical Oncology
2007-08-01

Triple-negative breast cancer: clinical features and patterns of recurrence

Steven A. Narod
2007-06-01

Antibodies to placental immunoregulatory ferritin with transfer of polyclonal lymphocytes arrest MCF-7 human breast cancer growth in a nude mouse model
2007-01-01

Prognostic markers in triple-negative breast cancer

Emad A. Rakha, Andrew Green, Ian Ellis
2007-05-03

Concentrations of TIMP1 mRNA splice variants and TIMP-1 protein are differentially associated with prognosis in primary breast cancer
2005-09-30

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

Eric Lander, Jill P. Mesirov, Sayan Mukherjee, Todd Golub, Pablo Tamayo, Benjamin L. Ebert, Scott L Pomeroy
2005-08-01

Reporting recommendations for tumor marker prognostic studies (REMARK).

Doug Altman
2003-07-07

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

Aron Goldhirsch, Beat Thürlimann
2002-06-01

Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival
2001-07-01

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

Articolo - wd:Q37634494

Benvenuto su Inventaire

la biblioteca dei tuoi amici e della tua comunità

ulteriori informazioni

non sei in linea